Cas:910462-43-0 4SC-202 manufacturer & supplier

We serve Chemical Name:4SC-202 CAS:910462-43-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4SC-202

Chemical Name:4SC-202
CAS.NO:910462-43-0
Synonyms:2-Propenamide, N-(2-aminophenyl)-3-[1-[[4-(1-methyl-1H-pyrazol-4-yl)phenyl]sulfonyl]-1H-pyrrol-3-yl]-, (2E)-;4SC-202 (free base);4SC-202freebase;(2E)-N-(2-Aminophenyl)-3-(1-{[4-(1-methyl-1H-pyrazol-4-yl)phenyl]sulfonyl}-1H-pyrrol-3-yl)acrylamide;4SC-202
Molecular Formula:C23H21N5O3S
Molecular Weight:447.509
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.3±0.1 g/cm3
Index of Refraction:1.672
PSA:120.39000
Exact Mass:447.136505
LogP:2.63

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Propenamide, N-(2-aminophenyl)-3-[1-[[4-(1-methyl-1H-pyrazol-4-yl)phenyl]sulfonyl]-1H-pyrrol-3-yl]-, (2E)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4SC-202 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Propenamide, N-(2-aminophenyl)-3-[1-[[4-(1-methyl-1H-pyrazol-4-yl)phenyl]sulfonyl]-1H-pyrrol-3-yl]-, (2E)- Use and application,(2E)-N-(2-Aminophenyl)-3-(1-{[4-(1-methyl-1H-pyrazol-4-yl)phenyl]sulfonyl}-1H-pyrrol-3-yl)acrylamide technical grade,usp/ep/jp grade.


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. 4SC-202 manufacturer In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 4SC-202 supplier In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 4SC-202 vendor From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. 4SC-202 factory In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks.